Breaking News! SET Suspends DOD from Trading after Letting 3Q Financial Statement Slips!

The Stock Exchange of Thailand (SET) has suspended the trading of DOD Biotech Public Company Limited (DOD)’s securities by posting “SP” sign after the company failed to submit the financial statements for the third quarter of 2019.

 

Following the incident in the morning of November 11, 2019, that DOD had published the news title: Notification of the exercise of the Warrants to purchase ordinary shares of DOD Biotech Public Company Limited (the “Company”) N0. 1 (DOD-W1) (29 November 2019), but the attached file was DOD’s 3Q19 financial statement instead of a notice of its DOD-W1.

Due to the wrong publication, SET had halted the trading of DOD by posting “H” sign, and requested the company to submit the financial statements for the third quarter of 2019, which led to the “SP” sign in the afternoon when DOD failed to submit the sign.

In the 3Q19 financial statement that was posted in the website of SET, DOD reported a net profit in the third quarter of 2019 at 15.13 million baht, decreased 79.20% from a net profit 72.74 million baht in the same quarter of last year. The decrease in net profit was due to the increase in cost of sales and service income by 90.68% and selling expenses by 763.11%.